AR could suppress the formation of HCC vasculogenic mimicry (VM) by downregulating circRNA7/miRNA7-5p/VE-Cadherin/Notch4 signaling pathways in HCC, which will help in the design of novel therapies against HCC (100). This evidence concerns the gene CDH5 and hepatocellular carcinoma.